Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.4%

6 terminated/withdrawn out of 111 trials

Success Rate

91.0%

+4.5% vs industry average

Late-Stage Pipeline

5%

6 trials in Phase 3/4

Results Transparency

25%

15 of 61 completed trials have results

Key Signals

23 recruiting15 with results4 withdrawn

Enrollment Performance

Analytics

N/A
47(48.0%)
Phase 2
26(26.5%)
Phase 1
19(19.4%)
Phase 4
4(4.1%)
Phase 3
2(2.0%)
98Total
N/A(47)
Phase 2(26)
Phase 1(19)
Phase 4(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (111)

Showing 20 of 111 trials
NCT03507257Active Not Recruiting

Longitudinal Early-onset Alzheimer's Disease Study Protocol

Role: collaborator

NCT07378800Not ApplicableActive Not Recruiting

Fostering Positive Care Interactions in Assisted Living

Role: collaborator

NCT05269394Phase 2Active Not Recruiting

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)

Role: collaborator

NCT05552157Phase 2Recruiting

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Role: collaborator

NCT06072963Phase 2Recruiting

COMMETS- Combination MCI Metabolic Syndrome

Role: collaborator

NCT06384573Phase 3Active Not Recruiting

DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

Role: collaborator

NCT01760005Phase 2Active Not Recruiting

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

Role: collaborator

NCT06647498Phase 2Recruiting

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

Role: collaborator

NCT05109169Phase 2Active Not Recruiting

METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia

Role: collaborator

NCT03888222Phase 2Completed

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Role: collaborator

NCT05184569Phase 1Active Not Recruiting

Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology

Role: collaborator

NCT05231798Phase 2Recruiting

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

Role: collaborator

NCT04629495Phase 2Active Not Recruiting

Rapamycin - Effects on Alzheimer's and Cognitive Health

Role: collaborator

NCT05573490Not ApplicableRecruiting

Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study

Role: collaborator

NCT06492967Not ApplicableCompleted

LatAm-FINGERS Initiative for Cognitive Change

Role: collaborator

NCT04902703Phase 2Recruiting

Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease

Role: collaborator

NCT06496425Not ApplicableRecruiting

Inspiring Seniors Towards Exercise Promotion to Protect Cognition

Role: collaborator

NCT06239688Not ApplicableRecruiting

Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce

Role: collaborator

NCT05780476Not ApplicableCompleted

A Novel VIRTUAL Reality Intervention for CAREgivers of People With Dementia (VirtualCare)

Role: collaborator

NCT04710030Phase 2Completed

Valacyclovir for Mild Cognitive Impairment

Role: collaborator